deltatrials
Active Not Recruiting PHASE4 INTERVENTIONAL 2-arm NCT03261206

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease (STATIC)

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease (STATIC) Study: A Randomized, Open-label, Non-inferiority Trial

Sponsor: Academic Medical Organization of Southwestern Ontario

Conditions Crohn Disease Remission
Interventions 5-ASA Withdrawal
Updated 16 times since 2017 Last updated: May 15, 2025 Started: Nov 20, 2017 Primary completion: Jun 30, 2026 Completion: Jun 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03261206, this PHASE4 trial focuses on Crohn Disease and Remission and remains ongoing. Sponsored by Academic Medical Organization of Southwestern Ontario, it has been updated 16 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2017 – ~Mar 2018 · 6 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Jan 2019 · 6 months · monthly snapshot~Jan 2019 – ~May 2019 · 4 months · monthly snapshot~May 2019 – ~Aug 2019 · 3 months · monthly snapshot~Aug 2019 – ~Jan 2020 · 5 months · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Mar 2023 · 22 months · monthly snapshot~Mar 2023 – ~Jun 2024 · 15 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshot~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting PHASE4

  2. Jun 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE4

  3. Sep 2024 — Jun 2025 [monthly]

    Active Not Recruiting PHASE4

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE4

  5. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE4

    Status: Recruiting → Active Not Recruiting

▶ Show 11 earlier versions

  1. Mar 2023 — Jun 2024 [monthly]

    Recruiting PHASE4

  2. May 2021 — Mar 2023 [monthly]

    Recruiting PHASE4

  3. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE4

  4. Jan 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  5. Aug 2019 — Jan 2020 [monthly]

    Recruiting PHASE4

  6. May 2019 — Aug 2019 [monthly]

    Recruiting PHASE4

  7. Jan 2019 — May 2019 [monthly]

    Recruiting PHASE4

  8. Jul 2018 — Jan 2019 [monthly]

    Recruiting PHASE4

  9. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE4

  10. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  11. Sep 2017 — Mar 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Academic Medical Organization of Southwestern Ontario
  • Alimentiv Inc.
Data source: Alimentiv Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Barnsley, United Kingdom , Basildon, United Kingdom , Bedford, United Kingdom , Blackburn, United Kingdom , Bristol, United Kingdom , Bury, United Kingdom , Bury St Edmunds, United Kingdom , Calgary, Canada , Castellana Grotte, Italy , Catania, Italy and 32 more locations